Clene, Inc. (CLNN)
6.56
-0.14
(-2.09%)
USD |
NASDAQ |
May 29, 16:00
6.605
+0.04
(+0.69%)
After-Hours: 20:00
Clene Total Liabilities (Quarterly) : 40.47M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.048M |
| Brainstorm Cell Therapeutics, Inc. | 11.76M |
| Precigen, Inc. | 118.39M |
| Summit Therapeutics, Inc. | 101.92M |
| Kezar Life Sciences, Inc. | 2.762M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.66M |
| Shareholders Equity (Quarterly) | -18.81M |
| Debt to Equity Ratio | -1.172 |
| Current Ratio | 1.935 |
| Net Debt Paydown Yield | -0.42% |